This week our In Focus section reviews the Centers for Medicare and Medicaid Services’ (CMS) announcement that the agency will explore three new prescription drug payment models in the Medicare and Medicaid programs:

• Medicare High-Value Drug List Model
• Cell and Gene Therapy (CGT) Access Model
• Accelerating Clinical Evidence Model